NuCana plc Gains 41.4%
Wed, Jul 13, 2022 at 08:33 PM
NuCana plc (NCNA:NASDAQ) jumped higher at $1.37, representing a gain of 41.4%. On Wed, Jul 13, 2022, NCNA:NASDAQ hit a New 2-Week High of $1.37. The stock appeared on our News Catalysts scanner on Mon, Jul 11, 2022 at 08:04 AM in the 'PATENT' category. From Wed, Jun 29, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days
About NuCana plc (NCNA:NASDAQ)
NuCana PLC is a clinical-stage biopharmaceutical company. It is focused on improving treatment outcomes for cancer patients by applying its ProTide technology.
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 47.15%
- ironSource Ltd. Class A (IS:NYSE), 47.09%
- TDH Holdings, Inc. (PETZ:NASDAQ), 42.23%
- NuCana plc (NCNA:NASDAQ), 41.4%
- Gossamer Bio, Inc. (GOSS:NASDAQ), 31.9%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 31.48%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 24.34%
- The OLB Group, Inc. (OLB:NASDAQ), 23.86%
- Velo3D Inc. (VLD:NYSE), 22.22%
- CinCor Pharma Inc. (CINC:NASDAQ), 21.13%